| Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial O Hermine, X Mariette, PL Tharaux, M Resche-Rigon, R Porcher, ... JAMA internal medicine 181 (1), 32-40, 2021 | 894 | 2021 |
| Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial PL Tharaux, G Pialoux, A Pavot, X Mariette, O Hermine, M Resche-Rigon, ... The Lancet Respiratory Medicine 9 (3), 295-304, 2021 | 279 | 2021 |
| Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients Y Allenbach, D Saadoun, G Maalouf, M Vieira, A Hellio, J Boddaert, ... PloS one 15 (10), e0240711, 2020 | 92 | 2020 |
| Neutrophil–platelet and monocyte–platelet aggregates in COVID-19 patients A Le Joncour, L Biard, M Vautier, H Bugaut, A Mekinian, G Maalouf, ... Thrombosis and haemostasis 120 (12), 1733-1735, 2020 | 51 | 2020 |
| Anti–tumor necrosis factor α versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French Uveitis Network M Leclercq, A Andrillon, G Maalouf, P Sève, P Bielefeld, J Gueudry, ... Ophthalmology 129 (5), 520-529, 2022 | 36 | 2022 |
| Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial X Mariette, O Hermine, PL Tharaux, M Resche-Rigon, R Porcher, ... The Lancet Rheumatology 4 (1), e24-e32, 2022 | 36 | 2022 |
| Biotherapies in uveitis M Leclercq, AC Desbois, F Domont, G Maalouf, S Touhami, P Cacoub, ... Journal of clinical medicine 9 (11), 3599, 2020 | 36 | 2020 |
| Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward A Le Joncour, C Frere, I Martin-Toutain, P Gougis, P Ghillani-Dalbin, ... Autoimmunity Reviews 20 (2), 102729, 2021 | 34 | 2021 |
| Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab F Nasr, E El Rassy, G Maalouf, C Azar, F Haddad, J Helou, C Robert European Journal of Cancer 91, 171-173, 2018 | 27 | 2018 |
| Lower relapses rate with infliximab versus adalimumab in sight-threatening uveitis: a multicenter study of 330 patients G Maalouf, A Andrillon, M Leclercq, P Sève, P Bielefeld, J Gueudry, ... American journal of ophthalmology 238, 173-180, 2022 | 13 | 2022 |
| Evolving spectrum of drug-induced uveitis at the era of immune checkpoint inhibitors results from the WHO's pharmacovigilance database C Anquetil, JE Salem, B Lebrun-Vignes, S Touhami, AC Desbois, ... Journal of autoimmunity 111, 102454, 2020 | 13 | 2020 |
| Neonatal osteomyelitis of the proximal femur: a case with ten-year follow-up and review of the literature F Haddad, S Sahyoun, G Maalouf Revue de Chirurgie Orthopedique et Reparatrice de L'appareil Moteur 93 (6 …, 2007 | 8 | 2007 |
| Tocilizumab in Behçet disease: a multicenter study of 30 patients MY Khitri, A Bartoli, G Maalouf, A Deroux, C Salvarani, G Emmi, ... The Journal of rheumatology 50 (7), 916-923, 2023 | 4 | 2023 |
| Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent … M Vieira, G Maalouf, M Hasan, A Le Joncour, E Karkeni, M Idir, D Amelin, ... Joint Bone Spine 88 (1), 105074, 2021 | 4 | 2021 |
| Uvéites: aspects cliniques et étiologiques G Maalouf, Z Osta, F Haddad, G Maalouly La Revue de Médecine Interne 38, A145-A146, 2017 | 3 | 2017 |
| Behçet’s Disease Uveitis M Joubert, AC Desbois, F Domont, A Ghembaza, A Le Joncour, A Mirouse, ... Journal of Clinical Medicine 12 (11), 3648, 2023 | 2 | 2023 |
| Effet bénéfique du traitement immunosuppresseur dans les uvéites non-antérieures de la sarcoïdose M Leclercq, P Sève, L Biard, M Vautier, F Domont, G Maalouf, G Leroux, ... La Revue de Médecine Interne 43, A97-A98, 2022 | 2 | 2022 |
| Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection C Fenioux, Y Allenbach, A Vozy, JÉ Salem, G Maalouf, M Vieira, ... Bulletin du Cancer 108 (6), 581-588, 2021 | 2 | 2021 |
| Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2 C Fenioux, Y Allenbach, A Vozy, JÉ Salem, G Maalouf, M Vieira, ... Bulletin du Cancer 108 (6), 581-588, 2021 | 1 | 2021 |
| Outcome and prognosis of isolated carotid vasculitis A Hankard, G Maalouf, J Laouni, O Espitia, C Agard, H De Boysson, ... Journal of Autoimmunity 146, 103242, 2024 | | 2024 |
